University of Notre Dame du Lac’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-31,101
| Closed | -$2.91M | – | 57 |
|
|
2019
Q1 | $2.91M | Sell |
31,101
-1,096
| -3% | -$102K | 0.65% | 47 |
|
|
2018
Q4 | $2.35M | Buy |
32,197
+2,371
| +8% | +$173K | 0.57% | 51 |
|
|
2018
Q3 | $2.61M | Buy |
29,826
+2,874
| +11% | +$251K | 0.49% | 63 |
|
|
2018
Q2 | $2.66M | Buy |
26,952
+4,822
| +22% | +$475K | 0.51% | 58 |
|
|
2018
Q1 | $2.64M | Buy |
22,130
+2,035
| +10% | +$242K | 0.49% | 63 |
|
|
2017
Q4 | $2.55M | Sell |
20,095
-11,802
| -37% | -$1.5M | 0.53% | 63 |
|
|
2017
Q3 | $3.75M | Sell |
31,897
-5,511
| -15% | -$648K | 1.04% | 50 |
|
|
2017
Q2 | $2.98M | Buy |
+37,408
| New | +$2.98M | 0.88% | 55 |
|